Back
  • ePosterkurzvortrag
  • eP021

Phase-2-Studie zu Cemiplimab bei Patienten mit lokal fortgeschrittenem Basalzellkarzinom nach Therapie mit Hedgehog-Inhibitoren: Langzeit-Follow-up

Appointment

Date:
Time:
Talk time:
Discussion time:
Location / Stream:
ePoster 3

Session

ePoster-Session 1.3: Non Melanoma Skin Cancer – PEK und BCC

Topic

  • Klinische Dermato-Onkologie: Non Melanoma Skin Cancer

Authors

PhD Alexander Stratigos (Athen / GR), MD Aleksandar Sekulic (Scottsdale / US), MD Ketty Perris (Rom / IT), Oliver Bechter (Leuven / BE), Sorilla Prey (Bordeaux / FR), PD Dr. med. Martin Kaatz (Gera / DE), MD Karl D. Lewis (Aurora / US), Nicole Basset-sequin (Paris / FR), MD Anne Lynn S. Chang (Stanford / US), Stephane Dalle (Lyon / FR), Almudena Fernández Orland (Seville / ES), Lisa Licitra (Milan / IT), Caroline Robert (Villejuif / FR), Dr. med. Claas Ulrich (Berlin / DE), Prof. Dr. med. Axel Hauschild (Kiel / DE), MD Michael R Migden (Houston / US), Prof. Dr. med. Reinhard Dummer (Zürich / CH), Suk-Young Yoo (Tarrytown / US), Ebony Coates (Tarrytown / US), Emmanuel Okoye (Tarrytown / US), Timothy Bowler (Tarrytown / US), Ioannis Bassukas (Ioannina / GR), Prof. Dr. med. Carmen Loquai (Mainz / DE), Vincenzo De Giorgi (Florence / IT), Zeynep Eroglu (Tampa / US), Prof. Dr. med. Ralf Gutzmer (Minden / DE), Prof. Dr. med. Jens Ulrich (Quedlinburg / DE), Susana Puig (Barcelona / ES), MD Frank Seebach (Tarrytown / US), MD, PhD Matthew G. Fury (Tarrytown / US)

    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Imprint
    • Privacy